Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cone

Showing results (201-210 of 368) with videos related to

Pageof 37
Sort By:
NIDA Research Monograph|January 1, 1991
Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphineE J Cone, S L Dickerson, W D Darwin, et al.
BMC Nursing|November 12, 2019
Mastery learning in a bachelor's of nursing program: the Roseman University of Health Sciences experienceMartin S Lipsky, Catherine J Cone, Susan Watson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1984
The metabolism and excretion of buprenorphine in humansE J Cone, C W Gorodetzky, D Yousefnejad, et al.
Instructional Course Lectures|January 1, 1990
Blood products: optimal use, conservation, and safetyJ Cone, L J Day, G K Johnson, et al.
Therapeutic Drug Monitoring|December 1, 2004
Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humansInsook Kim, Jonathan M Oyler, Eric T Moolchan, et al.
Drug and Alcohol Dependence|December 19, 2012
Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humansM A Huestis, E J Cone, S O Pirnay, et al.
Journal of Analytical Toxicology|October 24, 2000
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteersR A Jufer, A Wstadik, S L Walsh, et al.
Journal of Analytical Toxicology|October 24, 2000
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testingM A Huestis, E J Cone, C J Wong, et al.
Addiction (Abingdon, England)|July 31, 1998
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphineJ J Kuhlman, B Levine, R E Johnson, et al.
Journal of Pharmaceutical Sciences|May 1, 1988
Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogsP Jacob, N L Benowitz, J R Copeland, et al.
Pageof 37

Showing results (201-210 of 368) with videos related to

Sort By:
Pageof 37
NIDA Research Monograph|January 1, 1991
Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphineE J Cone, S L Dickerson, W D Darwin, et al.
BMC Nursing|November 12, 2019
Mastery learning in a bachelor's of nursing program: the Roseman University of Health Sciences experienceMartin S Lipsky, Catherine J Cone, Susan Watson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1984
The metabolism and excretion of buprenorphine in humansE J Cone, C W Gorodetzky, D Yousefnejad, et al.
Instructional Course Lectures|January 1, 1990
Blood products: optimal use, conservation, and safetyJ Cone, L J Day, G K Johnson, et al.
Therapeutic Drug Monitoring|December 1, 2004
Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humansInsook Kim, Jonathan M Oyler, Eric T Moolchan, et al.
Drug and Alcohol Dependence|December 19, 2012
Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humansM A Huestis, E J Cone, S O Pirnay, et al.
Journal of Analytical Toxicology|October 24, 2000
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteersR A Jufer, A Wstadik, S L Walsh, et al.
Journal of Analytical Toxicology|October 24, 2000
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testingM A Huestis, E J Cone, C J Wong, et al.
Addiction (Abingdon, England)|July 31, 1998
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphineJ J Kuhlman, B Levine, R E Johnson, et al.
Journal of Pharmaceutical Sciences|May 1, 1988
Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogsP Jacob, N L Benowitz, J R Copeland, et al.
Pageof 37